Morphine for refractory breathlessness in COPD: a randomized clinical intervention study Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020
Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial Source: Eur Respir J, 52 (3) 1800887; 10.1183/13993003.00887-2018 Year: 2018
Symptomatic benefit of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: Combined analysis from two 48-week studies Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Maintenance and reliever combination budesonide/formoterol therapy in asthma patients at risk of severe exacerbations: A randomised controlled trial Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013
Late Breaking Abstract - Open-label trial of budesonide/formoterol reliever therapy in mild asthma Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019
Effectiveness of a breathlessness service for patients suffering from breathlessness in advanced disease: pragmatic fast-track randomized controlled trial Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care Year: 2020
Indacaterol once-daily improves day and night-time symptom control in COPD patients: a 26-week study versus placebo and tiotropium Source: Annual Congress 2009 - New bronchodilators Year: 2009
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial Source: Eur Respir J, 53 (1) 1801270; 10.1183/13993003.01270-2018 Year: 2019
48-week administration of olodaterol QD via Respimat® vs placebo and formoterol BID in patients with COPD: Pooled safety analysis Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
Lung function efficacy of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: Two 48-week studies Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Formoterol as relief medication in asthma: the jury is still out Source: Eur Respir J 2003; 22: 723-724 Year: 2003
Budesonide/formoterol maintenance and reliever therapy for asthma compared to conventional best practice: a randomised real-life study Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019
Efficacy and safety of as-needed corticosteroid plus fast or short-acting beta-agonists monotherapy in patients with mild asthma: a meta-analysis of randomised controlled trials. Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Lung function efficacy of olodaterol QD delivered via Respimat® in COPD patients: Results from two 48-week studies Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013
QVA149 is more efficacious than tiotropium and salmeterol/fluticasone combination (SFC) in improving patient-reported outcomes and lung function in COPD patients with moderate-to-severe baseline dyspnoea: The IGNITE trials Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Efficacy of fluticasone on cough: a randomised controlled trial Source: Eur Respir J 2005; 25: 147-152 Year: 2005